- Category
- Micro (2023-24)
- Udyam number
- UDYAM-HR-01-0012579

About Indmark Biotech Private Limited
Data last updated:
Indmark Biotech Private Limited is a private limited company based in Jagadhri, Haryana, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 13 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24290HR2021PTC097637. Its GSTIN is 06AAGCI3067A1ZZ (Haryana).
The company has an authorised share capital of ₹15 Lakh and a paid-up capital of ₹15 Lakh. It is led by directors Mandeep Singh and Naresh Kumar.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at SCO 108 Basement Sector – 17 HUDA Jagadhri, Jagadhri, Haryana, India – 135001.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.03 Cr, a growth of 10% compared to the previous year. For the same year it recorded a net profit of ₹19,459 (net margin 0.2%) and EBITDA of ₹68,234 (EBITDA margin 0.7%). Revenue has grown at a compounded annual rate (CAGR) of 56% over three years.
Court records list 3 cases involving the company, including 3 filed by the company; 3 cases are pending.
Indmark Biotech Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-HR-01-0012579). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website indmarkbiotech.com.
Company details
Recognitions & Rankings of Indmark Biotech
Contact details
Indmark Biotech Private Limited's registered office is in Jagadhri, Haryana. Its website is indmarkbiotech.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Social Media
- Registered AddressSCO 108 Basement Sector – 17 HUDA Jagadhri, Jagadhri, Haryana, India – 135001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Indmark Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Indmark Biotech is wholesale and retail trade; repair of motor vehicles and motorcycles. In detail, this covers wholesale trade, except of motor vehicles and motorcycles.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Wholesale and retail trade; repair of motor vehicles and motorcycles | 46 | Wholesale trade, except of motor vehicles and motorcycles |
To see the full business activity and turnover split of Indmark Biotech Private Limited, buy the company report.
Financials of Indmark Biotech Private Limited
FY 2025 filings availableIndmark Biotech Private Limited reported revenue of ₹1.03 Cr (up 10% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 56% over three years, including 10% growth in the latest year. EBITDA rose 25% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profit and Loss Statement | ||||
| Revenue from Operations | ||||
| Other Income | ||||
| Total Revenue | ||||
| Cost of Materials Consumed | ||||
| Employee Benefit Expense | ||||
| Finance Costs | ||||
| Depreciation and Amortisation | ||||
| Other Expenses | ||||
| Total Expenses | ||||
| EBITDA | ₹68,234 | |||
| Profit Before Tax | ||||
| Tax Expense | ||||
| Net Profit (PAT) | ₹19,459 | |||
| Balance Sheet | ||||
| Share Capital | ||||
| Reserves and Surplus | ||||
| Net Worth (Total Equity) | ||||
| Long-term Borrowings | ||||
| Short-term Borrowings | ||||
| Trade Payables | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| EBITDA Margin | 0.7% | |||
| Net Profit Margin | 0.2% | |||
| Return on Equity (ROE) | ||||
| Return on Capital Employed (ROCE) | ||||
| Return on Assets (ROA) | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Quick Ratio | ||||
| Debt-to-Equity Ratio | ||||
| Interest Coverage Ratio | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Payable Days | ||||
| Inventory Days | ||||
| Revenue Growth | ||||
| Net Profit Growth | ||||
To see the full financial statements and ratios of Indmark Biotech Private Limited, buy the company report.
Board of directors of Indmark Biotech Private Limited
Indmark Biotech has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Mandeep Singh Also directs: Alenvision Pharma Private Limited, Alenrise Retail Private Limited | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
| Naresh Kumar | Director | 13 Sep 2021 | 5 Years 1 Months | Current |
Peer comparison
Indmark Biotech Private Limited is compared with the 10 companies closest to it by revenue in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Nexacare Lifesciences Private Limited | ₹1.03 Cr (FY 2025) | 35.0% | New Delhi, Delhi, India | |||
| Asharduledge India Private Limited | ₹1.03 Cr (FY 2024) | 143.0% | Bengaluru, Karnataka, India | |||
| SXKH Automation India Private Limited | ₹1.03 Cr (FY 2025) | -50.0% | Mayapuri, Delhi, India | |||
| Aegeus Lifesciences Private Limited | ₹1.03 Cr (FY 2024) | 5.0% | Nashik, Maharashtra, India | |||
| Greenacre Chemicals Pvt Ltd | ₹1.03 Cr (FY 2025) | -10.0% | Mumbai, Maharashtra, India | |||
| Indmark Biotech Private Limitedthis company | ₹1.03 Cr (FY 2025) | ₹19,459 | 0.2% | 10.0% | Jagadhri, Haryana, India | |
| Hiraba Engineers Private Limited | ₹1.03 Cr (FY 2025) | -39.0% | Borivlai East, Maharashtra, India | |||
| Shristi Commotrade Private Limited | ₹1.03 Cr (FY 2025) | -77.0% | Kolkata, West Bengal, India | |||
| Techgizmo Solutions Private Limited | ₹1.03 Cr (FY 2025) | 77.0% | Jaipur, Rajasthan, India | |||
| Ramadan Impex Private Limited | ₹1.03 Cr (FY 2025) | 1328.0% | Kanpur, Uttar Pradesh, India | |||
| Svvns Food Products Private Limited | ₹1.03 Cr (FY 2025) | Krishna, Andhra Pradesh, India |
To see the full peer comparison of Indmark Biotech Private Limited, buy the company report.
Auditor
Indmark Biotech Private Limited is audited by CA JYOTI GOYAL for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| CA JYOTI GOYAL | FY 2023 | 539129 |
Shareholding
The shareholding of Indmark Biotech Private Limited is on record for 2 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Indmark Biotech Private Limited, buy the company report.
Legal cases
Indmark Biotech Private Limited has 3 court cases on record: 3 filed by Indmark Biotech. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 3 | 0 | 3 |
Cases on record (2 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, Yamunanagar, Haryana | Court case (Nia Act) | Filed by the company against individuals | Pending |
| District court, Yamunanagar, Haryana | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Indmark Biotech Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Indmark Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Employees & EPFO
Indmark Biotech Private Limited has 1 active EPFO establishment as of Apr 06, 2024.
GST
Indmark Biotech has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 06AAGCI3067A1ZZ | Haryana | Active | 02 Oct 2021 |
To see the full GST registrations and return filing status of Indmark Biotech Private Limited, buy the company report.
Recent activity
Indmark Biotech Private Limited has 4 board changes on record since 2021: 3 appointments and 1 cessation. The latest: Vashist Sandhu ceased to be Director on 11 Aug 2023.
Frequently asked questions
Indmark Biotech is an active private limited company based in Jagadhri, Haryana, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 13 September 2021 (5+ years old) and is registered under CIN U24290HR2021PTC097637.
Indmark Biotech has 2 current directors:
- Mandeep Singh - Director
- Naresh Kumar - Director
The latest financial statements of Indmark Biotech on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Indmark Biotech is 06AAGCI3067A1ZZ, registered in Haryana.
The CIN (Corporate Identification Number) of Indmark Biotech is U24290HR2021PTC097637. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Indmark Biotech has 3 court cases on record: 3 filed by the company. 3 are pending.
Indmark Biotech was incorporated on 13 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Indmark Biotech by revenue are Nexacare Lifesciences Private Limited, Asharduledge India Private Limited, SXKH Automation India Private Limited, Aegeus Lifesciences Private Limited, Greenacre Chemicals Pvt Ltd and 5 more, all in the same principal business activity (wholesale trade, except of motor vehicles and motorcycles).
Vashist Sandhu ceased to be Director on 11 Aug 2023. Mandeep Singh was appointed as Director on 13 Sep 2021. Naresh Kumar was appointed as Director on 13 Sep 2021. Indmark Biotech has 4 board changes on record in total.
Yes, Indmark Biotech is registered as a micro enterprise under Udyam registration (number: UDYAM-HR-01-0012579).
Indmark Biotech can be reached through the website indmarkbiotech.com. Its registered office is in Jagadhri, Haryana, India.

